Boryung to boost sales of Kanarb in Central and South America

Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said recently that it will strengthen a strategic alliance with Stendhal SA, a leading pharmaceutical firm in Mexico in an effort to expand the sales of Kanarb (fimasartan) in 13 Central and South American countries.

Boryung officials said that Carlos Arenas Wiedfeldt, CEO of Stendhal, visited Boryung and its plant ...